Blog
RSS FeedPosted by Michael Wonder on 21 Feb 2019
How big pharma donations may influence public drug coverage
21 February 2019 - A new review of 372 patient group submissions to the CADTH – about whether new medicines should ...
Posted by Michael Wonder on 09 Feb 2019
U.S. PhRMA's fight to prevent lower Canadian drug prices
9 February 2019 - Drug industry turns up heat against Canada's drug price reforms. ...
Posted by Michael Wonder on 07 Feb 2019
Novartis and Lilly CEOs back Trump plans to cut drug prices
7 February 2019 - CEOs from Novartis and Eli Lilly have backed US government proposals to cut out “middlemen” in ...
Posted by Michael Wonder on 05 Feb 2019
Drug makers blame middlemen for high prices but still make huge profits
5 February 2019 - With drug prices climbing far faster than inflation, the cost of prescription medicine has become a ...
Posted by Michael Wonder on 04 Feb 2019
Don’t blame drug prices on ‘big pharma’
3 February 2019 - Law makers want lower list prices, but insurers are at fault for mismanaging plans. ...
Posted by Michael Wonder on 31 Jan 2019
CEOs hide as pressure on drug prices grows
30 January 2019 - This week, key committees in the House and Senate each held hearings on the rising cost ...
Posted by Michael Wonder on 31 Jan 2019
Net drug prices are falling, even as list prices increase
30 January 2019 - The net prices of drugs are falling even while list prices increase, as big pharma companies ...
Posted by Michael Wonder on 30 Jan 2019
On both ends of Capitol, both parties warn big pharma on drug prices
29 January 2019 - Price restraints are sure to face resistance from a small army of pharmaceutical lobbyists. ...
Posted by Michael Wonder on 29 Jan 2019
Big pharma should accept cap on drug price increases
28 January 2019 - The biopharmaceutical industry has made stunning progress in discovering and developing breakthrough medications. ...
Posted by Michael Wonder on 24 Jan 2019
Big pharma spends record millions on lobbying amid pressure to lower drug prices
23 January 2019 - The lobbying group for the pharmaceutical industry spent about $27.5 million on lobbying activities in 2018, ...
Posted by Michael Wonder on 23 Jan 2019
Modernising clinical trials for patients with cancer
23 January 2019 - Clinical trials involve evaluating and validating new therapies in humans and represent the fundamental means of making ...
Posted by Michael Wonder on 23 Jan 2019
Trump plan to force drug makers to advertise prices might work, but not if pharma gets its way
23 January 2019 - Trump administration proposal to require drug makers to advertise prices in television ads could dissuade consumers ...
Posted by Michael Wonder on 22 Jan 2019
In oversight inquiry, key Democrat seeking 10 years’ worth of pricing, sales, research data from drug companies
22 January 2019 - Republican Elijah Cummings, the Maryland Democrat chairing the House Oversight Committee, put the pharmaceutical industry on notice ...
Posted by Michael Wonder on 22 Jan 2019
Celgene, sold for $74 billion, leaves a legacy of chutzpah in science and drug pricing
22 January 2019 - Nina Kjellson was just two years out of college, working as a research associate at Oracle ...
Posted by Michael Wonder on 22 Jan 2019
Access, value and investment: making the right choices for a healthy Australia
22 January 2019 - Medicines Australia has today lodged its submission to the 2019-2020 Federal Budget. ...